Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Evaluation of Yervoy in Combination With Adoptive T Cell Transfer for the Treatment of Metastatic Melanoma Patients

NCT01988077 is registered in ClinicalTrials.gov with Sheba Medical Center as lead sponsor.

NCT NCT01988077
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01988077 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Evaluation of Yervoy in Combination With Adoptive T Cell Transfer for the Treatment of Metastatic Melanoma Patients
Lead sponsor
Sheba Medical Center
Phase
Phase 2
Overall status
Terminated
Start date
October 31, 2013
Completion date
October 25, 2018
Enrollment
2 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

a combination of adoptive t cell therapy and ipilimumab could increase the proportion of cr patients, and durability of response